The electrical stimulation devices market has seen considerable growth due to a variety of factors.
• In recent years, the market size for electrical stimulation devices has seen robust growth. It's projected to expand from $7.75 billion in 2024 to $8.5 billion in 2025, showcasing a compound annual growth rate (CAGR) of 9.6%. Factors such as the use in sports and fitness, inclination towards non-invasive treatments, clinical approvals, rising chronic health conditions, and regulatory backing have contributed to the growth during the historic period.
The Electrical Stimulation Devices market is expected to maintain its strong growth trajectory in upcoming years.
• Strong expansion is projected for the electrical stimulation devices market in the years to come, with its size predicted to reach $12.33 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.8%.
Factors contributing to this growth during the projected period include an aging population, an escalating number of chronic health illnesses, broadening clinical validation, and an encouraging regulatory environment. Other factors include emphasis on mental health and a heightened focus on preventive healthcare. Additionally, regulatory assistance and reimbursement policies, the rise in chronic health conditions, clinical research and evidence, movement towards non-invasive therapies, increased sporting and fitness applications are also anticipated to shape the market trends during the forecast period.
The growth of the electrical stimulation devices market is anticipated to be fuelled by the rising prevalence of muscle disorders. These inherited genetic diseases gradually lead to muscle weakness and can cause weakness or even paralysis, even when the nervous system is functioning properly. Electrical stimulation devices are beneficial in mitigating muscle weakness by creating a controlled and comfortable muscular contraction through skin electrodes and a portable stimulator. As per the Australian Institute of Health and Welfare, a government agency based in Australia, it was estimated in June 2024 that around 7.3 million Australians, or 29% of the population, were living with chronic musculoskeletal conditions in 2022. Among these, 4.0 million or 16% suffered from back problems, 3.7 million (15%) were dealing with arthritis, and 854,000 individuals or 3.4% were diagnosed with osteoporosis or osteopenia. Thus, the escalating prevalence of muscle disorders is driving the growth of the electrical stimulation devices market.
The electrical stimulation devices market covered in this report is segmented –
1) By Device Type: Deep Brain Stimulation Devices, Neuromuscular Electrical Stimulation Devices, Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices, Other Devices
2) By Application: Pain Management, Neurological And Movement Disorder Management, Musculoskeletal Disorder Management, Metabolism And GIT Management, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Deep Brain Stimulation Devices: Implantable Pulse Generators, Electrodes, Accessories
2) By Neuromuscular Electrical Stimulation Devices: Transcutaneous Electrical Nerve Stimulators (TENS), Functional Electrical Stimulation (FES) Devices, Surface Electrode Systems
3) By Sacral Nerve Stimulation Devices: Implanted Pulse Generators, Leads, External Testing Devices
4) By Spinal Cord Stimulation Devices: Implantable Pulse Generators, Leads, Battery Systems
5) By Other Devices: Vagus Nerve Stimulation Devices, Peripheral Nerve Stimulation Devices, Cochlear Implants
The emergence of cutting-edge technologies is a significant trend being observed in the electrical stimulation market. Principal market participants are launching sophisticated and FDA-sanctioned electrical stimulation devices for enhanced patient care. For instance, Abbott Laboratories, an American medical device company focused on electrical stimulation devices, declared in August 2022 that the US FDA granted approval for their Proclaim Plus device. This novel, high-tech spinal cord stimulation apparatus is based on FlexBurst360 therapy. It represents the next wave of BurstDR stimulation therapy that offers expanded myotomal coverage at reduced amplitudes compared to single-area stimulation. This facilitates personalized pain relief for various painful conditions and broadens the spectrum of therapies on offer.
Major companies operating in the electrical stimulation devices market include:
• Boston Scientific Corporation
• Abbott Laboratories
• DJO Global Inc.
• BTL Corporate Inc.
• Nevro Corp.
• NeuroMetrix Inc.
• Zynex Inc.
• BioMedical Life Systems
• RS Medical
• Biotronik Inc.
• CU Medical System Inc.
• Beijing Pins Medical Co.Ltd.
• MicroPort Scientific Corporation
• Koninklijke Philips N.V
• Bioinduction Ltd.
• Soterix Medical Inc.
• Medtronic plc
• MYOLYN
• Cogentix Medical Inc.
• Cyberonics Inc.
• Stimwave Technologies
• EndoStim Inc.
• SPR Therapeutics
• Nuvectra Corporation
• ElectroCore Inc.
• Axonics Modulation Technologies Inc.
• Inspire Medical Systems Inc.
• Second Sight Medical Products Inc.
• Cochlear Limited
North America was the largest region in the electrical stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the electrical stimulation devices market report during the forecast period. The regions covered in the electrical stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa